Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Molecular and Cellular Biology, Genetics

Abstract 4387: The clonal composition of colorectal cancer cell lines is defined by the maintenance of specific genomic imbalances, not by ongoing chromosomal instability

Darawalee Wangsa, Madison Schiefer, Daniel Bronder, Hesed Padilla-Nash, Irianna Torres, Lidia Warner, Yue Hu, E Michael Gertz, Russell Schwartz, Alejandro A. Schäffer, Daniela Hirsch, Timo Gaiser, Rüdiger Meyer, Jordi Camps, Kerstin Heselmeyer-Haddad and Thomas Ried
Darawalee Wangsa
National Cancer Inst., Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madison Schiefer
National Cancer Inst., Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Bronder
National Cancer Inst., Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hesed Padilla-Nash
National Cancer Inst., Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irianna Torres
National Cancer Inst., Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lidia Warner
National Cancer Inst., Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yue Hu
National Cancer Inst., Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Michael Gertz
National Center for Biotechnology Information, Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Russell Schwartz
Carnegie Mellon University, Pittsburgh, PA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandro A. Schäffer
National Center for Biotechnology Information, Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela Hirsch
University Medical Center Mannheim, University of Heidelberg, Heidelberg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timo Gaiser
University Medical Center Mannheim, University of Heidelberg, Heidelberg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rüdiger Meyer
National Cancer Inst., Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordi Camps
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerstin Heselmeyer-Haddad
National Cancer Inst., Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Ried
National Cancer Inst., Bethesda, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2017-4387 Published July 2017
  • Article
  • Info & Metrics
Loading
Proceedings: AACR Annual Meeting 2017; April 1-5, 2017; Washington, DC

Abstract

Tumor type specific genomic imbalances are the defining feature of carcinomas. It remains elusive to which extent intratumor heterogeneity and the clonal composition of cancer cell populations influences the genetic makeup and the phenotype of tumors. Many studies aimed at understanding the idiosyncrasies of cancer rely on the analysis of cell lines derived from primary tumors. In an attempt to decipher patterns of chromosomal heterogeneity we analyzed the widely used colorectal cancer cell lines DLD-1, HCT116, H508, SW620, HT-29 and SW480 using FISH and gene expression profiling. First, we applied a four color probe set that targets the oncogenes EGFR, CCND1, CDX2 and TERC and enumerated 200 metaphase spread, which included chromosome counts, and 5,000 interphase cells. Not surprisingly, the mismatch repair deficient cell lines DLD-1 and HCT116 were the most stable, whereas the aneuploid cell lines displayed a higher degree of instability. These results prompted us to apply our recently developed multiplex interphase FISH approach that allows copy number analysis of 12 gene loci in individual cells to 11 single cell derived clones from both HT-29 and SW480. SW480 was considerably more instable than HT-29. The parental lines consisted of major clones, which were propagated in the single cell derived lines. These analyses were complemented by gene expression profiling of the single cell derived clones and the parental cell lines using the Nanostring technology which measures expression levels of 770 cancer-associated genes. The SW480 clones separated into two distinct clusters that reflect discrete ploidy levels that were also present in the parental line. We then explored whether mutations of the BRAF (HT-29) and KRAS (SW480) genes observed in the parental lines were maintained in the derived clones; this was the case in all instances. Finally, we reconstructed phylogenetic trees of tumor evolution using a specifically developed algorithm, termed FISHTrees.

Our meticulous analysis of the clonal composition of these colorectal cancer models shows that, despite a certain degree of chromosomal instability, specific genomic imbalances are maintained. The results challenge the concept of ongoing chromosomal instability in cancer cell populations. This suggests a karyotype evolution that is driven by the necessity to arrive at a different plateau of chromosomal copy number as the driving force of carcinogenesis.

Citation Format: Darawalee Wangsa, Madison Schiefer, Daniel Bronder, Hesed Padilla-Nash, Irianna Torres, Lidia Warner, Yue Hu, E Michael Gertz, Russell Schwartz, Alejandro A. Schäffer, Daniela Hirsch, Timo Gaiser, Rüdiger Meyer, Jordi Camps, Kerstin Heselmeyer-Haddad, Thomas Ried. The clonal composition of colorectal cancer cell lines is defined by the maintenance of specific genomic imbalances, not by ongoing chromosomal instability [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 4387. doi:10.1158/1538-7445.AM2017-4387

  • ©2017 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 77 (13 Supplement)
July 2017
Volume 77, Issue 13 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 4387: The clonal composition of colorectal cancer cell lines is defined by the maintenance of specific genomic imbalances, not by ongoing chromosomal instability
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 4387: The clonal composition of colorectal cancer cell lines is defined by the maintenance of specific genomic imbalances, not by ongoing chromosomal instability
Darawalee Wangsa, Madison Schiefer, Daniel Bronder, Hesed Padilla-Nash, Irianna Torres, Lidia Warner, Yue Hu, E Michael Gertz, Russell Schwartz, Alejandro A. Schäffer, Daniela Hirsch, Timo Gaiser, Rüdiger Meyer, Jordi Camps, Kerstin Heselmeyer-Haddad and Thomas Ried
Cancer Res July 1 2017 (77) (13 Supplement) 4387; DOI: 10.1158/1538-7445.AM2017-4387

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 4387: The clonal composition of colorectal cancer cell lines is defined by the maintenance of specific genomic imbalances, not by ongoing chromosomal instability
Darawalee Wangsa, Madison Schiefer, Daniel Bronder, Hesed Padilla-Nash, Irianna Torres, Lidia Warner, Yue Hu, E Michael Gertz, Russell Schwartz, Alejandro A. Schäffer, Daniela Hirsch, Timo Gaiser, Rüdiger Meyer, Jordi Camps, Kerstin Heselmeyer-Haddad and Thomas Ried
Cancer Res July 1 2017 (77) (13 Supplement) 4387; DOI: 10.1158/1538-7445.AM2017-4387
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Molecular and Cellular Biology, Genetics

  • Abstract LB-267: Metabolic alterations in tumors cause cachexia in pancreatic cancer
  • Abstract LB-328: Mir-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44
  • Abstract LB-331: Advanced DNA-gold nanoprobe-based direct and sensitive quantification of novel microRNAs in prostate cancer
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013
  • Abstract LB-001: Impact of direct physician engagement with racial/ethnic minorities for oncology clinical trial access and accrual model
  • Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
Show more 3

Poster Presentations - Genomic Landscape of Head and Neck and GI Cancers

  • Abstract 4375: Complex interactions between genomic and epigenomic alterations in esophageal adenocarcinomas
  • Abstract 4391: Identification of novel cancer driver genes in hepatocellular carcinoma cells by RNAi screening method
  • Abstract 4370: ASNS and other significant mutations in head and neck squamous cell carcinomas: mutational landscape in a South Asian population
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement